Clinical Trial Update: Ketones for Opioid Craving [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining ketone-based therapy to reduce opioid craving in individuals with opioid use disorder; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Ketone-based therapy for opioid craving (ketones)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Opioid Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING